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doi:10.1016/j.ejvs.2010.11.020Abstract Introduction: There are potential benefits of percutaneous over open femoral
access for endovascular aneurysm repair (EVAR). Subsequent arterial closure using percuta-
neous devices is costly, whilst open repair risks potential wound complications and delayed
discharge. The technique of fascial closure has perceived advantages but its efficacy is
unclear. The aim of this study was to assess the safety and durability of fascial closure after
EVAR.
Methods: Patients undergoing EVAR using devices up to 24 French were considered. Exclusion
criteria included morbid obesity, high bifurcation, previous surgery, inadvertent high puncture,
arteries <5 mm and surgeon preference. The primary outcome measure was immediate tech-
nical success. All patients were followed-up clinically and with duplex at one and twelve
months to determine secondary complications.
Results: Over a one-year period fascial closure of 69 common femoral arteries was attempted
in 38 patients undergoing EVAR. Nine primary failures were due to haemorrhage in eight
arteries and thrombosis in one artery; all had immediate, uncomplicated open revision. Of
the 60 (87%) successful procedures, all had duplex surveillance at one month. Four pseudoa-
neurysms were identified, all treated conservatively.
At one year, 61 fascial closures (88%) were imaged, four patients had died and two were lost
to follow-up. Three of the pseudoaneurysms had resolved, the fourth patient had died (unre-
lated). No other complication attributable to fascial closure was found at either one or twelve
months.
Conclusion: Fascial closure is a safe, durable and cost-effective method of arterial closure
following EVAR. Success and complication rates are comparable to other techniques.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.51 706 3447; fax: þ44 151 706 5827.
ht.nhs.uk (R.K. Fisher).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Fascial Closure Following Percutaneous Endovascular Aneurysm Repair 347Introduction
There is evidence that percutaneous access for endovascular
aneurysm repair (EVAR) offers a clinical benefit in terms of
reduced blood loss, post-operative pain and complications
such as infection and seroma formation.1,2 In order to reap
the full benefit of a wholly percutaneous procedure, subse-
quent closure of the femoral artery is through suture-medi-
ated closure devices such as the Prostar XL or Perclose
(Abbott Laboratories. Abbott House, Maidenhead, UK.).
Femoral vessel dissection and closure following a percuta-
neous EVAR retains somebenefit regarding reduced infection
and bleeding, but loses the benefit of minimal access in
terms of pain and seroma formation. A potential compromise
is the fascial closure technique as described by Larzon et al.3
Potential problems with fascial closure include primary
failure due to haemorrhage and early thrombosis. Late
complications may include arterial stenosis or occlusion and
pseudoaneurysm formation. This study presents a case
series of patients undergoing percutaneous endovascular
aneurysm repair with fascial closure of the arteriotomy,
with the aim of assessing the early and late complications.
Fascial Closure Technique
The technique was largely similar to that described by Lar-
zon.3 One modification was the use of intra-operative ultra-
sound guidance to puncture the common femoral artery, as
evidence suggests improved technical success and reduced
complications.4 Care is required to ensure that an infrain-
guinal puncture of the common femoral artery is made. This
is guided by surface markings, palpation and the ultrasound
observation of the femoral head. Following completion of the
endovascular procedure, the guidewire and introducer were
left in situ. A longitudinal skin incision of 2.5e5 cmwasmade
and the inguinal ligament identified. The posterior aspect of
fascia lata, descending from the inguinal ligament, blends
with the femoral sheath. These layers were identified then
picked up by a purse string suture (0-Polydioxone). Care
was taken to avoid damage to the femoral artery, nerve or
vein. The sutures were tightened, tamponading the arterio-
tomy, as the introducer is gradually removed, leaving the
guidewire in situ. If bleeding occurred, the introducer was
repositioned within the artery, and open dissection and
arterial closure performed. If haemostasis was secured, the
wire was removed, the suture secured, and the skin closed.
Qualitative assessment of arterial flow detected any imme-
diate compromise. Fascial closure did not delay post-opera-
tive mobilisation. There was no need for additional
compression or bed rest and post procedural aspirin and deep
venous thrombosis prophylaxis was administered as normal.
Methods
All patients undergoing EVAR, under the care of three
consultants within a tertiary referral vascular unit were
considered for inclusion over a one-year period from
February 2008. Both relative and absolute exclusion criteria
for fascial closure were applied based upon clinical exam-
ination, pre-operative CTA and intra-operative findings.
When morbid obesity, eg. BMI over 35 kg/m2, requiredmanipulation of adipose tissue to obtain access, there was
potential to distort the anatomy, precipitating puncture
through the inguinal ligament. This represented an absolute
contraindication as fascial closure cannot be achieved
through the inguinal ligament. Similarly a high CFA bifur-
cation or puncture, left inadequate femoral artery to place
the proximal fascial stitch (approximately 1 cm). Previous
surgery sometimes resulted in anatomical distortion or
disruption of the fascial plane potentially precluding fascial
closure. Small arteries, <5 mm, had difficulty in accom-
modating the large sheaths necessary for EVAR and often
required formal reconstruction. A surgeon’s preference for
an alternative closure technique was influenced by
a combination of these factors. For the purpose of this
study, whilst fascial closure was considered for each case,
the surgeon was at liberty to choose an alternative tech-
nique based on the clinical scenario.
Sheath inner diameters of up to24Frenchon the ipsilateral
artery and 12e16 French on the contralateral side were
included. Data were collected prospectively. The primary
outcome measure was technical success defined as haemo-
stasis without arterial compromise. Secondary outcomes
includedhaematoma, requiringevacuation, thrombosis, need
for further surgery, wound infection, seroma, pseudoaneur-
ysm and common femoral artery stenosis or occlusion.
Clinical and duplex follow-up were at one month and
one year. Clinical follow-up was performed by vascular
surgeons. Duplex was performed by two experienced
vascular sonographers. The EVAR follow-up protocol was
modified to include detailed examination of the common
femoral arteries in order to accurately assess the outcome
of the fascial closure.
Results
During the study period EVAR was performed in 63 patients,
of whom 38 (60%) underwent attempted fascial closure,
median age 76 years (range 52e88), one female (3%).
Exclusion criteria accounted for the 25 cases in which
fascial closure was not attempted (Fig. 1). Fascial closure
was attempted in a total of 69 femoral arteries. In seven
patients unilateral attempt only was made due to surgeon
preference (3 patients), high puncture (1 patient) and 3
patients had a unilateral procedure. The procedures
included 31 standard and seven fenestrated EVARs.
A successful primary outcome was noted in 60 fascial
closures (87%), with 9 failures (13%). One intra-operative
femoral artery thrombosis required immediate revision and
immediate haemorrhage in 8 arteries, necessitated open
cut down and repair. Five of the primary failures (55%)
occurred within the first half of the cohort and 4 occurred
in the second half. One intra-operative iliac limb occlusion,
unrelated to the fascial closure, required a femoro-femoral
crossover graft.
All 69 arteries undergoing fascial closure had clinical and
duplex follow-up at one month. Four pseudoaneurysms, in
three patients were found. These were between 6 and
10 mm on ultrasound, asymptomatic and all treated
conservatively. An asymptomatic left iliac limb occlusion
occurred due to stenosis at the aorto-iliac junction of
a Zenith device (Cook Medical Inc. Bloomington, IN, USA)












Figure 1 Patient inclusion.
Table 1 Comparison of outcomes from this series, with
that of Larzon et al.3
Complications RLUH
n Z 69 (%)
Larzon et al.
n Z 131 (%)
Early
Primary failure 9 (13%) 16 (12%)
Haemorrhage 8 (12%) 9 (7%)
Occlusion/
thrombosis
1 (1%) 6 (5%)
Dissection 0 1 (1%)
1 month
Pseudoaneurysm 4 (7%) 4 (3%)
Stenosis/occlusion 0 5 (4%)




348 G.J. Harrison et al.CT imaging. This was treated conservatively. There were
no superficial wound complications, distal thrombo-embo-
lism or femoral nerve neuralgia. No patient required
a secondary intervention related to the fascial closure.
Of the 69 fascial closures, 61 arteries (88%) underwent
Duplex at 12 months; four patients had died and two were
lost to follow-up. Three of the recorded pseudoaneurysms
had resolved spontaneously. The other pseudoaneurysm
was in a patient who died one year following surgery from
renal and cardiac failure. There was also a common femoral
artery stenosis noted on follow-up duplex; this was however
reported on pre-operative CT angiogram. There were no
further complications found at one year and no patient
developed claudication.
Discussion
This study reports good primary technical success (87%)
with low early and late complication rates following fascial
closure after percutaneous EVAR. This suggests that the
technique is safe and durable. Our results also indicate that
peri-operative diligence can identify most complications
associated with the technique and enable them to be
rectified immediately. Concerns regarding late pseudoa-
neurysm formation or arterial stenosis appear unfounded
from the results of this study as all had resolved by one
year. Fascial closure appears to be a safe alternative
to open cut down following EVAR. There are also potential
benefits in terms of reduced post-operative pain and
seroma formation compared to open cut down, as the
fascia lata remains intact for a fascial closure, minimising
the subcutaneous dissection required. The technical
success rate in this study is similar to that reported by
Larzon et al. of 88%.3 Eight of their sixteen failures actually
required a return to theatre for revision, whereas all fail-
ures in the presented series were identified and revised
intra-operatively (Table 1). It is our observation that fascial
closure did not compromise subsequent open arterial
exposure when needed as the guidewire was left in situ
until satisfactory haemostasis was confirmed. If necessary,
the sheath was replaced and the artery dissected under
controlled conditions and sutured.Wholly percutaneous methods of arterial closure using
suture-mediated techniques have been reported, with
technical success rates of 94% and long-term complication
rates of 1% associated with the Prostar5 and Proglide device.6
These series demonstrated good technical success and
complication rates and reap the benefit of a wholly percu-
taneous approach. They incur considerable procedural cost
however, and our results would suggest that a fascial closure
technique has comparable outcomes but with minimal cost
implication.
Larzon et al. reported a pseudoaneurysm rate of 1%
following fascial closure, but did not incorporate routine
duplex follow-up, potentially missing small pseudoaneur-
ysms,3 The rate of pseudoaneurysm after percutaneous
closure devices has been reported as low as 1e2%,5 although
only pseudoaneurysms greater than 3 cm were considered
significant, potentially under-reporting their true incidence.
This study, however, scrutinized the femoral vessels with
Duplex at 1 and 12 months in an attempt to identify any
pseudoaneurysm formation. Whilst this yielded a compara-
tively higher rate than other studies (8%), the diameters
were all 1 cm and none required intervention. We there-
fore conclude that the rate of clinically significant pseu-
doaneurysm formation associated with the fascial closure
technique is similar to other methods of closure. Femoral
nerve neuralgia was avoided by careful identification of the
fascial layer, enabling accurate suture placement to avoid
the femoral nerve.
The equal distribution of technical failures over the
duration of this studywould suggest aminimal learning curve,
reflecting the simplicity of the technique and demonstrating
good generalisability. There is, however, an inevitable
subjectivity to the utilisation of the technique by surgeons,
and some may apply greater emphasis to relative contrain-
dications such as morbid obesity, scarring and length of
common femoral artery than others. Both this study and
Larzon’s paper3 report fascial closure in greater than 50% of
cases. One may anticipate this figure to rise with increased
experience and confidence.
Further benefit may be attributed to fascial closure
in terms of reduced scarring, thereby facilitating subsequent
re-interventions through either percutaneous or openmeans.
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return to theatre following percutaneous endovascular
procedures.7 Fascial closure is a “half-way house” in that the
dissection is limited to the subcutaneous fat and superficial
fascia. The fascia lata is not divided, nor is the artery formally
dissected or controlled. Secondary intervention is therefore
unlikely to be compromised. Although not objectively
assessed in this study, onemay anticipate a benefit associated
with the more superficial fascial closure in terms of post-
operative discomfort. This may allow early mobilisation and
hasten post-operative recovery and discharge.
There were no significant wound problems such as
infection, wound breakdown or seroma formation. This is
a significant benefit compared to the open access series by
Dalainas et al.8 who noted an 8% wound infection rate,
a 6.5% rate of local wound complications, including wound
necrosis and dehiscence and a 4.8% rate of lymphocele
formation. Femoral artery compromise and femoral nerve
complications may occur but their incidence is minimised
through accurate placement of the suture, facilitated by
adequate demonstration of the inguinal ligament and the
fascia lata. This requires an incision between 2.5 cm and
5 cm in the majority of patients.
Arterial calcification was not considered a contraindica-
tion and, indeed, may be a relative indication for the
technique rather than open repair or suture-mediated
closure devices, as there are some distinct advantages
in avoiding sutures in calcified vessels. We did not examine
the relationship between sheath size and complications
although one may intuitively anticipate a greater risk of
bleeding and pseudoaeurysm formation from a larger arte-
riotomy. Certainly, if the diameter of the sheath exceeds
that of the vessel then there is likely to be significant
extension of the arteriotomy around the lateral margins of
the vessel. A fascial suture, in such circumstances, may not
be sufficient to tamponade the haemorrhage.
Limitations to this study include relatively small
numbers and the selective nature of those patients who
actually had fascial closure. The application of this study to
female patients is particularly limited as there was only
one female included in the study. A randomised trial to
compare fascial closure, open cut down and percutaneous
closure devices including a cost analysis would be required
to give definitive information. Trial design must consider
the different technique-related exclusion criteria. Fascial
closure and percutaneous devices are both precluded byhigh bifurcation and inadvertent high puncture. All options
are complicated in obese patients. Surgeon preference may
also reduce the applicability of results.
Conclusion
Fascial closure offers a safe and cost-effective means of
securing haemostasis following percutaneous EVAR. It has
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